Synopsis
Synopsis
0
KDMF
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Chloroxacillin
2. Cloxacillin
3. Cloxacillin Sodium
4. Cloxacillin, Sodium
5. Sodium Cloxacillin
6. Sodium, Cloxacillin
7. Syntarpen
8. Tegopen
1. Cloxacillin Sodium
2. 7081-44-9
3. Cloxacillin Sodium Monohydrate
4. Bactopen
5. Sodium Cloxacillin Monohydrate
6. Tegopen
7. Orbenin
8. Cloxacillin Sodium Hydrate
9. Ekvacillin
10. Latocillin
11. Cloxypen
12. Methocillin-s
13. Cloxacillin Sodium Salt Monohydrate
14. Cloxacillin (sodium Monohydrate)
15. Cloxacillin (as Sodium)
16. Brl-1621
17. P-25
18. 65lcb00b4y
19. Chebi:34978
20. Monosodium (2s,5r,6r)-6-(3-(o-chlorophenyl)-5-methyl-4-isoxazolecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate Monohydrate
21. Sodium (2s,5r,6r)-6-(3-(2-chlorophenyl)-5-methylisoxazole-4-carboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate Hydrate
22. Sodium;(2s,5r,6r)-6-[[3-(2-chlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate;hydrate
23. Staphobristol-250
24. Orbenin Sodium Hydrate
25. Cloxacap
26. Prostaphlin-a Monohydrate
27. Brl-1621 Sodium Salt Monohydrate
28. Unii-65lcb00b4y
29. Cloxacillin Nataarium-1-wasser
30. Cloxapen (tn)
31. Tegopen (tn)
32. Cloxacillin Sodium [usan:usp:jan]
33. 642-78-4
34. Cloxacillin Sodium (usp)
35. Schembl41012
36. Chembl1200388
37. Cloxacillin Sodium [usan]
38. Dtxsid60110018
39. Cloxacillin Sodium [vandf]
40. Bcp13532
41. Cloxacillin Sodium [usp-rs]
42. Cloxacillin Sodium [who-dd]
43. Cloxacillin Sodium [who-ip]
44. Cloxacillin Sodium Hydrate (jp17)
45. Hy-b0466
46. Mfcd00150735
47. S2564
48. Akos015896310
49. Akos015962898
50. Ac-7623
51. Ccg-269503
52. Cloxacillin Sodium [green Book]
53. Cloxacillin Sodium [orange Book]
54. Cloxacillin Sodium Hydrate [jan]
55. Cloxacillin Sodium [ep Monograph]
56. Cloxacillin Sodium [usp Impurity]
57. 1,3-dichloro-7-bromoisoquinoline
58. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-(((3-(2-chlorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-3,3-dimethyl-7-oxo-, Monosodium Salt, Monohydrate, (2s-(2alpha,5alpha,6beta))-
59. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-(3-(o-chlorophenyl)-5-methyl-4-isoxazolecarboxamido)-3,3-dimethyl-7-oxo-, Sodium Salt, Monohydrate
60. As-60182
61. Cloxacillin Sodium [usp Monograph]
62. D02231
63. Ab01568256_01
64. Cloxacillin Sodium Salt Monohydrate [mi]
65. Q-200886
66. Cloxacillin Sodium Hydrate 100 Microg/ml In Methanol
67. Q27116347
68. Z2574937894
69. Cloxacillin Sodium, Antibiotic For Culture Media Use Only
70. Cloxacillin Sodium, European Pharmacopoeia (ep) Reference Standard
71. Cloxacillin Sodium Salt Monohydrate, Beta-lactamase-resistant Antibiotic
72. Cloxacillin Sodium Salt Monohydrate, Vetranal(tm), Analytical Standard
73. Cloxacillin Sodium, United States Pharmacopeia (usp) Reference Standard
74. Cloxacillin Sodium, Pharmaceutical Secondary Standard; Certified Reference Material
75. (2s,5r,6r)-6-[[3-(2-chlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
76. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-(((3-(2-chlorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-3,3-dimethyl-7-oxo-, Monosodium Salt, Monohydrate, (2s-(2.alpha.,5.alpha.,6.beta.))-
77. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-(((3-(2-chlorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-3,3-dimethyl-7-oxo-, Sodium Salt, Hydrate (1:1:1), (2s,5r,6r)-
78. Sodium (2s,5r,6r)-6-[[3-(2-chlorophenyl)-5-methyl1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate Hydrate
79. Sodium (2s,5r,6r)-6-[3-(2-chlorophenyl)-5-methyl-1,2-oxazole-4-amido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate Hydrate
80. Sodium 2,2-dimethyl-6beta-({[5-methyl-3-(2-chlorophenyl)isoxazol-4-yl]carbonyl}amino)penam-3alpha-carboxylate Hydrate
1. 642-78-4
2. Cloxacillin Sodium Anhydrous
3. Sodium Orbenin
4. Syntarpen Sodium Salt
5. Monosodium Cloxacillin
6. Sodium Syntarpen
7. Austrastaph
8. Staphybiotic
9. Ankerbin
10. Ekvacillin
11. Gelstaph
12. Cloxacillin Sodium Salt
| Molecular Weight | 475.9 g/mol |
|---|---|
| Molecular Formula | C19H19ClN3NaO6S |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 4 |
| Exact Mass | 475.0580785 g/mol |
| Monoisotopic Mass | 475.0580785 g/mol |
| Topological Polar Surface Area | 142 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 728 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
RLD : No
TE Code :
Brand Name : CLOXAPEN
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 250MG BASE
Approval Date : 1982-01-01
Application Number : 61806
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : CLOXAPEN
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 500MG BASE
Approval Date : 1982-01-01
Application Number : 61806
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : CLOXAPEN
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 250MG BASE
Approval Date : 1982-01-01
Application Number : 62233
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : CLOXAPEN
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 500MG BASE
Approval Date : 1982-01-01
Application Number : 62233
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
12
PharmaCompass offers a list of Cloxacillin Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cloxacillin Sodium manufacturer or Cloxacillin Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cloxacillin Sodium manufacturer or Cloxacillin Sodium supplier.
PharmaCompass also assists you with knowing the Cloxacillin Sodium API Price utilized in the formulation of products. Cloxacillin Sodium API Price is not always fixed or binding as the Cloxacillin Sodium Price is obtained through a variety of data sources. The Cloxacillin Sodium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Orbenin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Orbenin, including repackagers and relabelers. The FDA regulates Orbenin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Orbenin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Orbenin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Orbenin supplier is an individual or a company that provides Orbenin active pharmaceutical ingredient (API) or Orbenin finished formulations upon request. The Orbenin suppliers may include Orbenin API manufacturers, exporters, distributors and traders.
click here to find a list of Orbenin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Orbenin DMF (Drug Master File) is a document detailing the whole manufacturing process of Orbenin active pharmaceutical ingredient (API) in detail. Different forms of Orbenin DMFs exist exist since differing nations have different regulations, such as Orbenin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Orbenin DMF submitted to regulatory agencies in the US is known as a USDMF. Orbenin USDMF includes data on Orbenin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Orbenin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Orbenin suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Orbenin Drug Master File in Japan (Orbenin JDMF) empowers Orbenin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Orbenin JDMF during the approval evaluation for pharmaceutical products. At the time of Orbenin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Orbenin suppliers with JDMF on PharmaCompass.
A Orbenin CEP of the European Pharmacopoeia monograph is often referred to as a Orbenin Certificate of Suitability (COS). The purpose of a Orbenin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Orbenin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Orbenin to their clients by showing that a Orbenin CEP has been issued for it. The manufacturer submits a Orbenin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Orbenin CEP holder for the record. Additionally, the data presented in the Orbenin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Orbenin DMF.
A Orbenin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Orbenin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Orbenin suppliers with CEP (COS) on PharmaCompass.
A Orbenin written confirmation (Orbenin WC) is an official document issued by a regulatory agency to a Orbenin manufacturer, verifying that the manufacturing facility of a Orbenin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Orbenin APIs or Orbenin finished pharmaceutical products to another nation, regulatory agencies frequently require a Orbenin WC (written confirmation) as part of the regulatory process.
click here to find a list of Orbenin suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Orbenin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Orbenin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Orbenin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Orbenin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Orbenin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Orbenin suppliers with NDC on PharmaCompass.
Orbenin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Orbenin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Orbenin GMP manufacturer or Orbenin GMP API supplier for your needs.
A Orbenin CoA (Certificate of Analysis) is a formal document that attests to Orbenin's compliance with Orbenin specifications and serves as a tool for batch-level quality control.
Orbenin CoA mostly includes findings from lab analyses of a specific batch. For each Orbenin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Orbenin may be tested according to a variety of international standards, such as European Pharmacopoeia (Orbenin EP), Orbenin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Orbenin USP).
